Proxy advisory firm Institutional Shareholder Services on Friday recommended shareholders of drugmaker Bristol-Myers Squibb Co shareholders vote in favor of its proposed US$74 billion takeover of rival Celgene Corp.
from Latest https://ift.tt/2Uk8Tsq
from Latest https://ift.tt/2Uk8Tsq
Comments
Post a Comment